Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SEI Medical PCLBKK:SEI 19 9-Day RSI is 57.78 as of Aug. 09, 2026. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 125 Medical Distribution companies, SEI Medical PCL ranks worse than 66.4% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-09), SEI Medical PCL's 9-Day RSI is 57.78.
The industry rank for SEI Medical PCL's 9-Day RSI or its related term are showing as below:
BKK:SEI's 9-Day RSI is ranked worse than 66.4% of 125
companies
in the Medical Distribution industry
Industry Median: 52.92
vs BKK:SEI: 57.78
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SEI Medical PCL 9-Day RSI Related Terms
BKK:SEI vs MCK, COR, CAH: 9-Day RSI Comparison
For the Medical Distribution subindustry, SEI Medical PCL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SEI Medical PCL 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SEI Medical PCL's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where SEI Medical PCL's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SEI Medical PCL (BKK:SEI) has a 9-Day RSI of 57.78 as of Aug. 09, 2026. According to the industry distribution chart, SEI Medical PCL ranks #83 out of 125 companies in the Medical Distribution industry, placing it in the top 66.4%.
Is SEI Medical PCL's 9-Day RSI too high?
SEI Medical PCL's current 9-Day RSI is 57.78. The Medical Distribution industry median 9-Day RSI is 52.92. SEI Medical PCL's value of 57.78 is 9.2% above this industry median. Based on the distribution chart, SEI Medical PCL ranks #83 out of 125 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's 9-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SEI Medical PCL ranks #83 out of 125 companies for 9-Day RSI. This places SEI Medical PCL in the lower half of its industry. The industry median 9-Day RSI is 52.92. SEI Medical PCL's value of 57.78 is 9.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 52.92, based on 125 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SEI Medical PCL's current 9-Day RSI of 57.78 is 9.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 52.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SEI Medical PCL's current 9-Day RSI is 57.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current 9-Day RSI of 57.78. The current 9-Day RSI is 57.78 and 9.2% above the Medical Distribution industry median of 52.92. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current 9-Day RSI is 57.78 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score
Get the complete analysis for BKK:SEI
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SEI has been successfully added to your 
